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Alzheimer's diseasePost-mortem and imaging studies have observed that white matter (WM) degenerates in a pattern inverse to
myelin development, suggesting preferential regional vulnerabilities inﬂuencing cognitive decline in AD. This
study appliednovelWM tract integrity (WMTI)metrics derived fromdiffusional kurtosis imaging (DKI) to exam-
ine WM tissue properties in AD within this framework. Using data from amnestic mild cognitive impairment
(aMCI, n = 12), AD (n = 14), and normal control (NC; n = 15) subjects, mixedmodels revealed interaction ef-
fects: speciﬁcWMTImetrics of axonal density andmyelin integrity (i.e. axonal water fraction, radial extra-axonal
diffusivity) in late-myelinating tracts (i.e. superior and inferior longitudinal fasciculi) changed in the course
of disease, but were stable in the initial stages for early-myelinating tracts (i.e. posterior limb of the internal cap-
sule, cerebral peduncles).WMTImetrics in late-myelinating tracts correlatedwith semantic verbal ﬂuency, a cog-
nitive function known to decline in AD. These ﬁndings corroborate the preferential vulnerability of late-
myelinating tracts, and illustrate an application of WMTI metrics to characterizing the regional course of WM
changes in AD.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Alzheimer's disease (AD) and its associated cognitive and functional
declines are hypothesized to arise from the preferential vulnerability of
late-myelinating areas. Speciﬁcally, post-mortem studies have shown
that brain regions that are “last in,” or that myelinate later in develop-
ment, are typically “ﬁrst out,” or the most vulnerable to aging and the
ﬁrst areas to manifest neurodegenerative pathology (Braak and Braak,
1996). In vivo neuroimaging studies using diffusion tensor imagingtic mild cognitive impairment;
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placement of water to probe the microstructural integrity of brain
whitematter (WM) (Basser and Pierpaoli, 1996). Brieﬂy, the directional
variability of water diffusion in WM is indexed by fractional anisotropy
(FA), where higher FA values imply greater directional coherence of
WM ﬁber bundles. Consistent with post-mortem ﬁndings, prior studies
show that compared to controls, AD patients have lower FA values in
late-myelinating regions relative to early-myelinating areas (Choi,
2005; Gao et al., 2011; O'Dwyer et al., 2011a; Stricker et al., 2009).
While this effect could be largely attributable to myelin breakdown,
conﬂicting observations in the larger DTI literature on AD suggest that
the mechanisms and the course of these changes are likely complex
and synergistic (i.e. involving both Wallerian degeneration and myelin
breakdown; O'Dwyer et al., 2011a; Sexton et al., 2011).
The ambiguous pathogenic interpretation of these DTI results is
partly due to the limited speciﬁcity of FA, which is affected by several
factors such asmyelination, axondensity or diameter, and intravoxel in-
coherence of ﬁber orientation (Beaulieu, 2002; Schmierer et al., 2007).
In AD, gliosis as well as myelin and axonal loss may inﬂuence FA values
(Gouw et al., 2008). Thus, FA by itself is insufﬁcient to disentangle the
individual contributions of each degenerative process. Alternatively, si-
multaneously assessing changes inmultiple diffusion indices could pro-
vide more insight into underlying AD pathology (Acosta-Cabroneroved.
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et al., 2011b; Shu et al., 2011). It has been proposed, for example, that
radial diffusivity reﬂects myelin loss (Budde et al., 2008; Klawiter
et al., 2011; Song et al., 2002), while axial diffusivity suggests axonal
damage (Budde et al., 2008; Song et al., 2003). Should a change in radial
diffusivity, but not in axial diffusivity, be observed, one might infer that
myelin loss rather than axonal damage has occurred. However, radial
diffusivity has also been found to indicate axonal loss (Klawiter et al.,
2011). Thus, like FA, radial and axial diffusivities are informative, but
have limited speciﬁcity to distinct neurodegenerative processes.
Furthermore, because of its assumption of Gaussian water diffusion,
DTI is restricted in its ability to fully exploit all of the information avail-
able from diffusionMRI. Diffusional kurtosis imaging (DKI) is a clinically
feasible extension of DTI that examines the additional contribution of
non-Gaussian diffusion effects known to occur in the brain as a result
of its microstructural complexity (Jensen and Helpern, 2010; Jensen
et al., 2005). DKI provides both the diffusion and kurtosis tensors,
from which all of the DTI-compatible metrics, such as the mean, radial
and axial diffusivities are obtained, as well as the mean, radial and
axial kurtoses, which quantify the diffusional non-Gaussianity. This
added information can potentially improve the characterization of sub-
tle tissue microstructural changes in neurodegenerative diseases, such
as AD.
Nonetheless, such empirical diffusion measures only provide an in-
direct characterization of microstructure, making their physical mean-
ing in terms of speciﬁc tissue properties uncertain. To overcome this
limitation of pathological non-speciﬁcity, recent developments in the
ﬁeld of diffusionMRI have focused on biophysical modeling of the diffu-
sion MRI signal to allow for more precise in vivo detection of subtle
changes in biological tissue. In line with this effort, several advanced
models have been proposed to interpret the diffusion MRI signal in
brainWM (cf. Fieremans et al., 2011; Panagiotaki et al., 2012). In partic-
ular, our group has proposed a method that relates DKI-compatible
metrics directly to WM microstructure using a speciﬁc WM model
(Fieremans et al., 2011). This WM model applies to WM regions with
highly aligned ﬁber bundles, and partitions water into two compart-
ments, an intra-axonal space and an extra-axonal space. The fraction
of diffusion MRI–visible water in the intra-axonal space represents the
axonal water fraction (AWF). In addition, the diffusion metrics for the
two compartments can be separately calculated. We refer to these
WMmodel-derived parameters as WM tract integrity (WMTI) metrics,
since they aremost applicable to well-deﬁnedWM tracts. In addition to
the AWF, the WMTI metrics include the intrinsic axonal diffusivity
(Daxon), the radial extra-axonal diffusivity (De,⊥), and the axial extra-
axonal diffusivity (De,∥).
The WMTI metrics are by design more directly related to the micro-
structure than empirical DTI and DKI parameters. The AWF and De,⊥ are
sensitive to demyelination and axonal loss, whereas the axial compart-
ment diffusivities, Daxon and De,∥, are speciﬁcally sensitive to structural
changes along the axon bundle in the intra-axonal space (e.g., due to ax-
onal beading (Fieremans et al., 2012c;Hui et al., 2012)) and in the extra-
axonal space (e.g., due to gliosis, loss of oligodendrocytes, extracellular
inﬂammation), respectively. As a result, Daxon and De,∥ are both far less
sensitive to changes in myelin and axonal geometry transverse to the
axon bundle, a ﬁnding that is consistent with our recent analysis of
healthy human development data (Fieremans et al., 2012a). In addition,
recent biophysical modeling (Fieremans et al., 2012a, 2012b, 2012c)
suggests that the AWF may be most affected by axonal loss, while De,⊥
is most indicative of myelin integrity, with an elevated value being in-
dicative ofmyelin breakdown. Currently, these are provisional interpre-
tations that require further investigation. One such effort underway is a
histological validation of these metrics in a mouse model of demyelin-
ation that is currently under review (cf. Falangola et al., 2012).
Of particular relevance to AD, we reported in a clinical study that the
WMTImetrics demonstrated high sensitivity and diagnostic accuracy in
detecting WM changes through the course of AD (Fieremans et al.,2013). The transition from normal aging to the amnestic mild cognitive
impairment (aMCI) stage was characterized by increased radial extra-
axonal diffusivity (De,⊥), consistent with widespread myelin break-
down, whereas a decrease in AWF occurred later in the disease from
aMCI to AD, as would result from a reduction in axonal density. More-
over, our initial voxelwise analysis suggested that these extra-axonal
changes appeared to preferentially occur in late-myelinating tracts ear-
lier in the disease, whereas the AWF declined in both late- and early-
myelinating tracts in the later stages. Although these initial ﬁndings
provide qualitative support of the vulnerability of late-myelinating
tracts in AD, a quantitative analysis that explicitly compares regionspre-
viously deﬁned as early- or late-myelinating in prior studies of cognitive
aging and AD (Brickman et al., 2012a; Stricker et al., 2009) would pro-
vide a more rigorous test of this hypothesis.
The purpose of this study was to apply WMTI metrics to clarify the
tract-speciﬁc changes in WM tissue properties, using cross-sectional
data from demographically similar groups of subjects that simulate
the course of AD. We hypothesized that late-myelinating tracts would
degenerate through the course of AD in contrast to relatively stable
early-myelinating tracts, using theWMTI metrics to investigate wheth-
er these changes resulted from degeneration in axonal or myelin integ-
rity. We further expected that these WMTI metrics in late-myelinating
tracts would be associated with semantic verbal ﬂuency, a cognitive
function known to decline through the course of AD (Henry et al.,
2004) and facilitated by late-myelinating regions (Brickman et al.,
2006; Chen et al., 2009).
2. Materials and methods
2.1. Subjects and procedures
Subjects were recruited from the New York University (NYU)
Alzheimer's Disease Center to undergo a full clinical research evaluation
per Uniform Data Set procedures for Alzheimer's Disease Centers
(Morris et al., 2006), and an MRI brain scan. Diagnoses were rendered
by consensus and followed research criteria: NC subjects (n = 15)
had no evidence of dementia or MCI and had a Clinical Dementia Rating
(CDR) global score of 0; aMCI subjects (n = 12) were deemed to be in
the precursor stage to AD dementia as deﬁned by having a self- and/or
informant-reported memory complaint, memory impairment based
on performance that was at least−1.5 standard deviations below the
Wechsler Memory Scale — Revised normative mean for age on Logical
Memory-II or other memory subtests, CDR = 0.5, and no dementia
(Petersen, 2004); AD subjects (n = 14) were given a diagnosis based
on the Diagnostic and Statistical Manual of Mental Disorders (Fourth
Edition; (American Psychiatric Association, 2000) and the National In-
stitute of Neurological and Communicative Diseases and Stroke/
Alzheimer's Disease and Related Disorders Association criteria for prob-
able AD (McKhann et al., 1984), CDR ≥ 0.5 (range 0.5–2.0), and were
not deemed to have anymedical, neurological, or psychiatric conditions
that could otherwise account for the dementia. The three groups did not
statistically differ in demographic characteristics (Table 1). Nonetheless,
due to the sensitivity of theWMTI metrics and diffusion MRI metrics in
general (Sullivan and Pfefferbaum, 2006) to age, age was included as a
covariate in all analyses. Supplementary Table 1 presents the subjects'
raw scores on the neuropsychological tests from the Uniform Data Set.
Although all three groups reported histories of vascular risk factors
or events that have been identiﬁed in the literature as contributors to
the pathogenesis of AD (Kalaria et al., 2012), for the subjects in this
study, these factors were not deemed to be the primary etiology for
the observed cognitive impairment per consensus diagnosis. The extent
to which the current clinical and research criteria preclude deﬁnitive
conclusions regarding the relative contributions of vascular and neuro-
degenerative pathologies is a current topic of interest (Kling et al., 2013)
that unfortunately cannot be directly addressed in this study. Nonethe-
less, as the groups in this study did not statistically differ in self-reported
Table 1
Demographic and medical history descriptive statistics for Normal Controls (NC),











n (%) n (%) n (%)
Demographics
Age (yrs, mean ± SD) 77.54 ± 4.01 79.05 ± 7.23 78.30 ± 9.55 0.15 0.87
Female 10 (66) 6 (50) 8 (57) 0.78 0.68
Education (yrs,
mean ± SD)
16.14 ± 2.51 15.08 ± 3.66 15.14 ± 2.83 0.54 0.59
Right handed 13 (87) 11 (92) 13 (93) 1.94 0.75
White race 14 (93) 10 (83) 12 (86) 4.46 0.62
Medical history
Hypertension 8 (53) 8 (67) 4 (29) 3.95 0.14
Hypercholesterolemia 12 (80) 9 (75) 6 (43) 3.09 0.21
Diabetes 2 (13) 1 (8) 1 (7) 0.35 0.84
Thyroid disease 3 (20) 2 (17) 1 (7) 1.01 0.60
Cardiac arrest 2 (13) 3 (25) 1 (7) 2.01 0.37
Cardiac bypass 1 (7) 1 (8) 0 (0) 1.13 0.57
Stroke or TIA 1 (7) 1 (8) 1 (7) 0.03 0.99
Depression within the
past two years
4 (27) 1 (8) 4 (29) 1.85 0.40
Note: TIA = Transient Ischemic Attack.
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to a vascular risk history are at least comparable across the groups.
2.2. MRI acquisition and image processing
MRI experiments were conducted on a 3 T TIM TrioMR system (Sie-
mens Medical Solutions, Erlangen, Germany) with the parameters asFig. 1. Regions of interest, depicting the early-myelinating (blue) and late-myelinating (gree
PLIC = posterior limb of the internal capsule, CP = cerebral peduncle.previously reported (Fieremans et al., 2013). Brieﬂy, theMRprotocol in-
cluded 3D T1-weighted imaging for anatomical reference using a mag-
netization prepared rapid acquisition of gradient echoes (MPRAGE)
sequence, and diffusion imaging with three b-values (0, 1000,
2000 s/mm2) along 30 diffusion encoding directions using a single
shot twice refocused echo-planar sequence. In-house image process-
ing software (diffusional kurtosis estimator, DKE; Tabesh et al., 2011;
http://www.nitrc.org/projects/dke) was used for checking image
quality, motion correction, and for estimating the diffusion tensor
and diffusional kurtosis tensors. The tensors were then used to de-
rive the DKI-acquired parametric maps of mean diffusivity (MD),
axial diffusivity (D∥), radial diffusivity (D⊥), and fractional anisotro-
py (FA), mean kurtosis (MK), axial kurtosis (K∥), and radial kurtosis
(K⊥), as well as the WMTI metrics (Fieremans et al., 2011).
As in prior imaging studies that compared the relative vulnerability
of early- and late-myelinating tracts in aging and AD (Brickman et al.,
2012a; Stricker et al., 2009), the regions of interest (ROI) were bilateral
early-myelinating tracts (i.e. posterior limb of the internal capsule
[PLIC], cerebral peduncle [CP]) and late-myelinating tracts (i.e. superior
longitudinal fasciculus [SLF], inferior longitudinal fasciculus [ILF]) (see
Fig. 1). Using FMRIB's Software Library (FSL, Analysis Group, FMRIB,
Oxford, UK), the individual FA maps were non-linearly registered to
the FMRIB58 FA template and resampled to the 1 × 1 × 1 mm3
Montreal Neurological Institute (MNI) 152 space. A mean FA map over
all subjects was created. The tract ROIs were obtained from the Johns
Hopkins University (JHU) WM atlas (Mori et al., 2005). The ROIs were
thresholded to FA ≥ 0.4 to restrict further analysis to voxels consisting
of single ﬁber orientations as necessary for the derivation of the WMTI
metrics. Means and standard deviations over the ROIs were extracted
for each WMTI metric. The means of the metrics from the left and
right ROIs were calculated. In addition, the metrics for the PLIC and CP,n) tracts. SLF = superior longitudinal fasciculus, ILF = inferior longitudinal fasciculus,
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myelinating and late-myelinating tract metrics.
2.3. Semantic verbal ﬂuency
Semantic verbal ﬂuency was assessed using the animal and vegeta-
ble tests. Subjects were asked to name as many animals as they could
in 60 s, and vegetables in a separate 60-second trial. To facilitate inter-
pretation and analyses, the raw total of correct responses for each test
was converted to a z-score using normative data for age, sex, and
years of education from the National Alzheimer's Coordinating Centers
Uniform Data Set (Shirk et al., 2011), and an average z-score composite
was generated for each subject. One AD subject did not complete these
tests for unknown reasons. As expected, the three groups differed on
this semantic verbal ﬂuency composite z-score [F(2, 37) = 14.24,
p b 0.001], with the AD subjects (−1.97 ± 1.11) scoring signiﬁcantly
lower (p b 0.01) than the NC (0.77 ± 1.22) and aMCI (−0.06 ± 1.77)
subjects.
2.4. Statistical analyses
To test our a priori hypothesis, we conducted mixed model ANOVAs
for each WMTI metric with between-group (i.e. NC, aMCI, AD) and
within-group (i.e. early-, late-myelinating) factors, and with age as a co-
variate. That is, we tested whether there was a signiﬁcant interaction ef-
fect between groups and regionalWMTImetrics. Because of the relatively
modest sample sizes in this preliminary study, we did not adjust the sig-
niﬁcance threshold for the four mixed models tested. We conducted
Spearman's correlations (two-tailed) between the WMTI metrics of the
late-myelinating tracts and semantic verbal ﬂuency composite z-scores.
To account for age, the age-residualized WMTI metrics were used,
where age was regressed onto each metric. A conservative Bonferroni-
corrected signiﬁcance value was set to (p b 0.05/4 = 0.0125) to mini-
mize Type I error from the multiple pairwise correlations between the
four regional metrics and the semantic verbal ﬂuency composite z-
score. To identify whichWMTI metric best correlated with semantic ver-
bal ﬂuency, Hotelling's t/Steiger's Z-tests for correlated correlations were
conducted to statistically test for the relative strength of each correlationTable 2
ANCOVA post-hoc results for normal control (NC), amnestic MCI (aMCI) and Alzheimer's disea
Metric Region of interest NC (n = 15) aMCI (n = 12)
Mean ± SD Mean ± SD
AWF Early-myelinating 0.42 ± 0.02 0.42 ± 0.01
ICp 0.42 ± 0.02 0.42 ± 0.02
CP 0.42 ± 0.02 0.43 ± 0.01
Late-myelinating** 0.38 ± 0.03 0.37 ± 0.02
SLF** 0.40 ± 0.03 0.40 ± 0.03
ILF* 0.35 ± 0.03 0.34 ± 0.03
Daxon
[μm2/ms]
Early-myelinating 0.84 ± 0.05 0.86 ± 0.05
ICp 0.82 ± 0.07 0.84 ± 0.07
CP 0.87 ± 0.06 0.89 ± 0.03
Late-myelinating 0.88 ± 0.07 0.87 ± 0.05
SLF** 0.89 ± 0.08 0.87 ± 0.08
ILF 0.88 ± 0.08 0.86 ± 0.04
De,∥
[μm2/ms]
Early-myelinating** 2.16 ± 0.15 2.27 ± 0.08
ICp* 2.01 ± 0.14 2.11 ± 0.07
CP* 2.30 ± 0.17 2.43 ± 0.09
Late-myelinating** 2.17 ± 0.10 2.22 ± 0.06
SLF 2.02 ± 0.08 2.05 ± 0.06
ILF** 2.31 ± 0.16 2.39 ± 0.12
De,⊥
[μm2/ms]
Early-myelinating* 0.93 ± 0.09 0.99 ± 0.09
ICp 0.83 ± 0.08 0.88 ± 0.09
CP** 1.02 ± 0.11 1.10 ± 0.10
Late-myelinating** 1.10 ± 0.08 1.16 ± 0.07
SLF** 1.06 ± 0.07 1.09 ± 0.04
ILF** 1.15 ± 0.10 1.24 ± 0.13
Note: Asterisks indicate signiﬁcant omnibus ANCOVA results for each regional metric, where *
Daxon = intra-axonal diffusivity, extra-axonal axial (De,∥) and radial (De,⊥) diffusivities.coefﬁcient. Analyses were conducted using IBM SPSS version 20
(Armonk, NY).
3. Results
3.1. A decrease in AWF and an increase in De,⊥ occur primarily in late-
myelinating tracts through the course of AD
Table 2 reports the summary statistics, while Fig. 2 depicts the re-
sults of the mixed models. In support of our ﬁrst hypothesis, there was
an interaction effect for AWF [F(2, 37) = 3.89, p b 0.05, η2 = 0.17];
AWF in early-myelinating tracts did not differ across the groups,where-
as AWF in late-myelinating tracts was lower in AD than in NC and aMCI.
There was a within-group main effect for tract type [F(1, 37) = 223.57,
p b 0.001, η2 = 0.86]; AWF in late-myelinating tracts was signiﬁcantly
lower than AWF in early-myelinating tracts. The model for De,⊥
approached signiﬁcance [F(2, 37) = 3.05, p = 0.059, η2 = 0.14]; De,⊥
in early-myelinating tracts was higher in AD than NC, but De,⊥ in late-
myelinating tracts was higher in AD than both NC and aMCI. There
was a within-group main effect for tract type [F(1, 37) = 192.77,
p b 0.001, η2 = 0.84]; De,⊥ in LM tracts was signiﬁcantly higher than
in EM tracts. Per partial eta-squared values, these models have large ef-
fect sizes (Cohen, 1969; Richardson, 2011). In contrast, themixedmodel
wasnot signiﬁcant forDe,∥ [F(2, 37) = 1.46, ns]. Themodel forDaxonwas
signiﬁcant [F(2, 37) = 3.80, p b 0.05,η2 = 0.17], but therewere no sig-
niﬁcant within- or between-group main effects.
3.2. Extra-axonal diffusivities correlate with semantic verbal ﬂuency
Table 3 reports Spearman's correlations between the age-
residualized WMTI metrics of the late-myelinating tract composites
and the semantic verbal ﬂuency z-scores for all the subjects. Semantic
verbal ﬂuency was correlated with the WMTI metrics of AWF and
extra-axonal diffusivities (i.e. De,∥, De,⊥) in the expected directions.
That is, worse semantic verbal ﬂuency was associated with greater
extra-axonal diffusivities and with lower AWF in late-myelinating
tracts. However, semantic verbal ﬂuency correlated more strongly
with De,⊥ than with AWF [Hotelling's t(37) = −4.28, p b 0.001], andse (AD) subjects, controlling for age, for each regional WMTI metric (n = 41).
AD (n = 14) NC v. aMCI aMCI v. AD NC v. AD
Mean ± SD p-Value p-Value p-Value
0.41 ± 0.03 0.77 0.20 0.65
0.41 ± 0.03 0.95 0.58 0.86
0.41 ± 0.04 0.64 0.10 0.56
0.34 ± 0.04 1.00 0.02 0.02
0.37 ± 0.05 0.99 0.01 0.01
0.32 ± 0.04 1.00 0.08 0.05
0.87 ± 0.08 0.72 1.00 0.58
0.86 ± 0.09 0.90 0.81 0.37
0.87 ± 0.09 0.58 0.80 0.98
0.83 ± 0.05 0.95 0.23 0.06
0.79 ± 0.09 0.97 0.04 b0.01
0.87 ± 0.05 0.97 0.98 1.00
2.29 ± 0.09 0.05 0.94 0.01
2.13 ± 0.09 0.09 0.96 0.02
2.45 ± 0.11 0.07 0.94 0.02
2.29 ± 0.11 0.51 0.11 b0.01
2.05 ± 0.09 0.84 0.98 0.59
2.53 ± 0.15 0.54 0.04 b0.01
1.04 ± 0.13 0.41 0.37 0.01
0.91 ± 0.13 0.61 0.64 0.08
1.16 ± 0.16 0.39 0.29 b0.01
1.29 ± 0.19 0.64 0.01 b0.01
1.18 ± 0.17 0.92 0.02 b0.01
1.40 ± 0.23 0.54 0.03 b0.01
p b 0.05, **p b 0.01. WMTI = white matter tract integrity, AWF = axonal water fraction,
Fig. 2.Mixedmodel results. Bar graphsdepicting themixedmodels for (a)Daxon, (b)De,∥, (c) AWF, and (d)De,⊥. Graphs (c) and (d) depict interaction effects. That is, AWFdecreases andDe,⊥
increases in late-myelinating tracts (green bars) through the course of AD, in contrast to early-myelinating tracts (blue bars) that remain stable until later in the disease when De,⊥, too,
increases. Whiskers = 95% conﬁdence intervals. NC = normal controls, aMCI = amnestic mild cognitive impairment, AD = Alzheimer's disease. *p b 0.05, ***p b 0.001. (For interpre-
tation of the references to colors in this ﬁgure legend, the reader is referred to the web version of this article.)
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correlations between semantic verbal ﬂuency and both metrics of
extra-axonal diffusivity (i.e. De,⊥ and De,∥) were not signiﬁcantly differ-
ent [Hotelling's t(37) = −1.60, ns], indicating that semantic verbalTable 3
Spearman's correlations between age-residualized WMTI metrics in late-myelinating
tracts and the semantic verbal ﬂuency z-score (n = 40).
Semantic verbal ﬂuency (z-score)
r p-value
AWF in late-myelinating tracts 0.42 0.007
Daxon in late-myelinating tracts 0.15 0.366
De,∥ in late-myelinating tracts −0.44 0.004
De,⊥ in late-myelinating tracts −0.61 b0.001
Note:WMTI = whitematter tract integrity, AWF = axonalwater fraction,Daxon = intra-
axonal diffusivity, extra-axonal axial (De,∥) and radial (De,⊥) diffusivities.ﬂuency is preferentially associated with extra-axonal diffusivity rather
than AWF.
4. Discussion
This study sought to apply recently proposed WMTI metrics as de-
rived from DKI in subject groups that simulate the progression of AD,
to further elucidate the speciﬁc changes in WM. Our results show that
both AWF decreases and De,⊥ increases in late-myelinating tracts
through the course of AD, in contrast to the early-myelinating tracts,
wherein these metrics were stable until later in the disease. In the
late-myelinating tracts, AWF and De,⊥ values were signiﬁcantly lower
and higher, respectively, than their corresponding values in early-
myelinating tracts, which is consistent with WM ontogeny. In addition,
increased De,⊥ and De,∥ in late-myelinating tracts were associated with
decreased semantic verbal ﬂuency, a cognitive function that declines
in AD and ismediated by these tracts. These ﬁndings have the following
69A. Benitez et al. / NeuroImage: Clinical 4 (2014) 64–71implications regarding the regional progression of WM changes in AD,
and identify potential biomarkers of a neurobiological substrate of cog-
nitive dysfunction.4.1. Changes in WMTI metrics reﬂect preferential vulnerability of
late-myelinating tracts in AD
The preferential vulnerability of late-myelinating areas to aging and
AD is a proposed mechanism by which cognition declines. This trend
has been referred to as “retrogenesis,” or a “return to childhood” insofar
as the disease is characterized by a decline in cognitive and functional
abilities that inversely mirrors the acquisition of these skills in develop-
ment (Reisberg et al., 1999). Post-mortem studies indicate that patho-
logical markers of neurodegenerative diseases ﬁrst develop in areas
that are last to myelinate prior to affecting early-myelinating areas
(Braak and Braak, 1996), and that a loss of myelin integrity accounts
for cognitive decline (Peters et al., 1996;Wallin et al., 1989). Mechanis-
tically, this occurs because when myelin breaks down with aging, the
homeostatic remyelination process is characterized by the formation
of thinner and shorter intermodal lengths of myelin, resulting in a re-
duced rate of conduction along affected myelinated nerve ﬁbers
(Fancy et al., 2011; Peters, 2009). In vivo detection methods of this
known biological process are key to the development of potential tar-
gets that could ameliorate the burden of cognitive impairment in neuro-
degenerative diseases of aging. In accord with other studies (Bartzokis
et al., 2012; Brickman et al., 2012a; Stricker et al., 2009), our study con-
tributes to this literature by providing in vivo corroboration of known
myelopathology.
Speciﬁcally, these ﬁndings support the potential use of novel WMTI
metrics to clarify the particular tissue properties of WM that undergo
changes through the course of AD. The results of ourmixedmodels sug-
gest that axonal density,what AWF ismodeled to estimate, preferential-
ly decreases in late-myelinating tracts, particularly at the later stages of
AD (Fig. 2c). Similarly, myelin breakdown (as estimated by increased
De,⊥) in late-myelinating tracts also occurs through the course of AD,
especially in the later stages when such decline likewise occurs in
early-myelinating tracts (Fig. 2d). Neither changes in the intra-axonal
environment (Daxon; indicating axonal injury), nor in axial extra-
axonal diffusivity (De,∥; suggesting alterations in extra-axonal diffusivity
due to gliosis, loss of oligodendrocytes, inﬂammation and the like),
demonstrated the hypothesized pattern.
These dissociations corroborate and extend known processes in AD.
First, AWF as a metric of axonal density loss may be a marker of the
widespread neuronal degeneration resulting from intra-cellular neuroﬁ-
brillary changes in late-myelinating areas (Braak and Braak, 1996),
whereas the integrity of axonal projections is relatively unaffected unlike
in acute ischemia (Hui et al., 2012). While cerebrovascular disease is
known to exacerbate or even precipitate AD (Kalaria et al., 2012), further
work could disentangle the extent to whichWMTI metrics can reﬂect its
acute or chronic effects on AD. Second, the speciﬁcity of our ﬁndings im-
plicating myelin breakdown relates to previous ﬁndings from other
groups. It is possible that along with neuroﬁbrillary changes, dysregula-
tion in the homeostatic functions of myelin is a crucial mechanism by
which cognitive and functional declines arise in AD (Bartzokis, 2004). In-
deed,while themixedmodel forDe,∥wasnot signiﬁcant (Fig. 2b), thedata
trends are consistent with glial activation in both late- and early-
myelinating tracts through the disease course. Myelin breakdown may
especially be observed in late-myelinating tracts that, givenWMontoge-
ny, are particularly vulnerable toAD, butmay also be observed later in the
disease in early-myelinating tracts. For both processes of axonal density
loss and myelin breakdown, the results of this study suggest that these
declines are most apparent in the dementia stage, indicating that these
particularWMregionsmay be involved in later stages of disease. Howev-
er, our previously published voxelwise analyses did implicate otherwide-
spread regions, mostly late-myelinating than early-myelinating, assigniﬁcantly differentiating normal controls from aMCI (Fieremans
et al., 2013).
4.2. Extra-axonal diffusivity in late-myelinating tracts and semantic verbal
ﬂuency
These previously described ﬁndings relating to degeneration in axo-
nal density and myelin integrity in late-myelinating tracts presuppose
that these changesmay inﬂuence the declines in higher-order cognition
that characterize the course of AD. To add to this, we identiﬁed that my-
elin integrity in particular (as indicated by WMTI metrics of extra-
axonal diffusivity) was more speciﬁcally correlated with semantic ver-
bal ﬂuency, a cognitive function that is also known to decline in AD
and is believed to be facilitated by the late-myelinating longitudinal fas-
ciculi of interest in this study (Brickman et al., 2006; Chen et al., 2009;
Henry et al., 2004). Thus, not only are these WMTI metrics potentially
sensitive to speciﬁc regional differences in degeneration as the disease
progresses, but these metrics also are functionally relevant and can
serve as potentialmarkers of the neuroanatomical substrate of cognitive
decline, which are in much need (Salthouse, 2011).
4.3. WMTI metrics may speciﬁcally reﬂect the particular vulnerability of
late-myelinating tracts in AD compared to conventional diffusion metrics
TheDKI acquisition implemented in this study also provides the con-
ventional diffusionmetrics via DKE post-processing. Thus, while not the
focus of the current study, follow-up mixed models were conducted
using the conventional diffusion metrics instead to examine the extent
to which these metrics also reﬂect the hypothesized effects. As can be
seen in Supplementary Table 2, mixed models were signiﬁcant for the
mean diffusivity, radial diffusivity, and axial kurtosis. Of note, mean
and radial diffusivities demonstrated group differences in both early-
and late-myelinating tracts, whereas the current ﬁndings speciﬁcally
supported the hypothesized interaction effect (i.e. preferential decline
in late-myelinating tracts). Although these data appear supportive of
the WMTI metrics, it must be emphasized that these are suggestive
trends at best due to themultiple tests conductedwith themodest sam-
ple size in this preliminary study. Future replications and extensions of
this work can hopefully be adequately powered to conductmore robust
statistical tests of these comparative effects.
4.4. Clinical implications and future directions
Although most typiﬁed by medial temporal atrophy and memory
decline, AD is increasingly regarded as a disease that affects widespread
brain tissue, as evidenced by the growing number of neuroimaging
studies that implicate various other regions, tracts, and networks
(Risacher and Saykin, 2013), and the neuropsychological literature
that has long documented declines in non-memory domains (e.g. se-
mantic verbal ﬂuency) as also pathognomonic of the disease (Albert
et al., 2001; Salmon et al., 2002). Accordingly, this studyprovides a dem-
onstration of howWMTImetrics, as obtained fromDKI, can indicate the
microstructural integrity of key tracts associated with cognition that
also undergo degeneration in the course of AD. Similar to the ease
with which neuropsychological testing is implemented and yields
meaningful indices, it is the intention ofmanydevelopers of neuroimag-
ing biomarkers to provide functionally meaningful quantitative metrics
that can be derived from clinically-feasible imaging sequences with rel-
atively straightforward post-processing. Given the promising ﬁndings
in this preliminary study, future work incorporating complementary
imaging modalities may help clarify other contributors to WM changes
and cognition in AD.
These results can inform potential interventions by enabling the
consideration of alternative prevention or treatment strategies that tar-
get mediators of axonal density or myelin integrity in late-myelinating
regions. Considering the preferential vulnerability of these areas as
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uents or on the processes that perturb its homeostatic functions may
provide alternative or complementary strategies for addressing this
widespread brain disease that affectsmore than one region and involves
varied pathologies (e.g. Bartzokis, 2012; Hider et al., 2011). The ﬁeld is
in need of effective therapeutics that can perhaps beneﬁt other diseases
in which cognitive decline, as inﬂuenced by loss of WM integrity, is a
similar problem. Subsequent research must employ experimental de-
signs ormore robust statistical analyses that directly test the association
between metrics of WM integrity and cognitive function to bolster this
argument.
4.5. Limitations
Despite the large effect sizes found here that provide in vivo corrob-
oration of known neuropathological processes, this study has limita-
tions. First, since the patient groups studied here represent a cross-
sectional simulation of the temporal course of AD, corroboration of
these ﬁndings using a longitudinal design is necessary to fully elucidate
the primacy or saliency of regional differences through the course of dis-
ease (O'Dwyer et al., 2011a; Sexton et al., 2011), althoughour priorﬁnd-
ings imply that myelin breakdown may precede axonal density loss
(Fieremans et al., 2013). Future clinical research must also endeavor to
more thoroughly characterize the presence and potential contribution
of vascular risk factors in the event that these may bemeaningful effect
modiﬁers.
Second, other WM pathologies identiﬁed via non-diffusion imaging
techniques were not incorporated here. For instance, T2-weighted imag-
ing identiﬁesWMhyperintensities that represent a variety of pathologies
that may increase the likelihood of dementia onset (Brickman et al.,
2012b; van Straaten et al., 2008). However, in our data set, the prevalence
of WM hyperintensities was not statistically signiﬁcantly different be-
tween the groups (cf. Fieremans et al., 2013), suggesting that the effects
introduced by these hyperintensities that are not already detected by
DKI would not systematically alter our results. The relative contribution
of these in vivo imaging techniques to quantifying WM integrity, be it
through quantifying WM hyperintensities or diffusion properties, is un-
known and beyond the scope of this paper, but is currently under active
investigation (Maillard et al., 2013). Multi-modal neuroimaging studies
incorporating WMTI metrics would be ideal, provided that this future
work is sufﬁciently powered to incorporate various other metrics.
Third, there are many other tracts identiﬁed in recent in vivo imag-
ing studies as either late- or early-myelinating that could have been
considered here (Kochunov et al., 2012; Lebel et al., 2012). However,
given the modest sample size and the preliminary nature of this study,
focusing the analyses on regions that have been identiﬁed in previous
studies was considered both conceptually and practically justiﬁed. Our
decision to combine the left and right regions in the analyses for the
sake of consistencywith prior imaging studies that hypothesized similar
effects (Brickman et al., 2012a; Stricker et al., 2009) could also bear fur-
ther scrutiny in future studies, although follow-up analyses of these
data reveal no signiﬁcant differences between each WMTI metric of
the corresponding left and right regions (data not shown). Similarly, fu-
ture work can explore whether certain tracts that contributed to the
composites used here were primarily driving the results. For instance,
in the aforementioned studies, FA in the ILF showed greater age-
related (Brickman et al., 2012a) and AD-related (Stricker et al., 2009) ef-
fects.We found contrasting results in that FA in the SLF appeared to dis-
tinguish the groups more so than the ILF (Supplementary Table 2), and
that the tract-speciﬁc group differences did not systematically favor ILF
effects across the WMTI metrics (Table 2). Regardless, replication of
these ﬁndings with larger samples is necessary before any deﬁnitive
conclusions can bemade. Lastly, subsequentwork could also further in-
vestigate the functional relevance of these metrics by employing psy-
chometrically robust measures of cognition beyond those employed
here.4.6. Conclusions
We applied recent innovations in modeling of WM microstructure
using DKI-derived parameters to demonstrate the extent to which
WMTI metrics can clarify the vulnerability of late-myelinating tracts in
AD. Our results indicate that the primary changes in WM appear to be
related to the loss of axonal density andmyelin breakdown, particularly
in late-myelinating tracts, through the course of the disease. Albeit pre-
liminary, the large effects found in this study suggest that these metrics
can potentially serve as robust in vivo biomarkers of disease progression
that warrant further investigation.
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